RARA CRAFT DATABASE for FDA Medical Devices
510(k)K253654

FDA DEVICE FACTS

IntelliVue Measurement Rack 6000 (867317)

Philips Medizin Systeme Böblingen GmbH

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMarch 30, 2026PRODUCT CODEMSXCLINICAL AREACardiology

Indications for use

INTENDED USE The devices are intended to be used for monitoring and recording of, and to generate alarms for, multiple physiological parameters of adults, pediatric patients, and neonates. INDICATIONS FOR USE The devices are indicated for use by healthcare professionals whenever there is a need for monitoring the physiological parameters of patients. The monitors are only for use on one patient at a time. The monitors are not therapeutic devices. Caution: The monitors are for prescription use only. The ECG measurement is indicated to be used for diagnostic recording of rhythm and detailed morphology of complex cardiac complexes according to AAMI EC 11. ST-segment monitoring is indicated for use with adult patients only and is not clinically validated for neonatal and pediatric patients. BIS is indicated for use under the direct supervision of a licensed healthcare practitioner or by personnel trained in its proper use. It is indicated for adult and pediatric patients within a hospital or medical facility providing patient care to monitor the state of the brain by acquiring EEG signals. BIS may be used as an aid in monitoring the effects of certain anesthetic agents. Use of BIS monitoring to help guide anesthetic administration may be associated with a reduction in the incidence of awareness with recall in adults during general anesthesia and sedation. The SSC Sepsis Protocol, in the ProtocolWatch clinical decision-support tool, is indicated for adult patients only. The derived measurement Pulse Pressure Variation (PPV) is indicated for use with sedated patients receiving controlled mechanical ventilation and mainly free from cardiac arrhythmia. PPV has been validated only for adult patients. IntelliVue NMT is indicated to be used as an objective neuromuscular-transmission monitor that measures muscle response to electrical stimulation of a peripheral nerve. The NMT Module is indicated for adult and pediatric patients. The Masimo rainbow SET measurement is indicated for noninvasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2), pulse rate, carboxyhemoglobin saturation (SpCO), methemoglobin saturation (SpMet), total hemoglobin concentration (SpHb), and/or respiratory rate (RRac). It is indicated for both no-motion and motion conditions and for patients who are well or poorly perfused. The noninvasive Masimo O3 Regional Oximeter System and accessories are indicated as an adjunct monitor of absolute and trended regional hemoglobin oxygen saturation of blood (rSO2) in the cerebral region under the sensors. They are indicated for adults weighing at least 40 kg and pediatric patients weighing more than 5 kg and less than 40 kg in healthcare environments. The SedLine Sedation Monitor is indicated to monitor the state of the brain by real-time acquisition and processing of EEG signals. The system includes the Patient State Index (PSI), a proprietary computed EEG variable related to the effect of anesthetic agents. The agents include Alfentanil, Desflurane, Fentanyl, Isoflurane, Nitrous Oxide, Propofol, Remifentanil, and Sevoflurane. The SedLine Sedation Monitor is indicated for adult patients 18 years of age and older in the operating room, intensive care unit, and clinical research laboratory. The Predictive Temperature module is indicated to provide an accurate prediction of patient temperature using oral, axillary, or rectal body sites, or to provide an actual temperature reading in continuous-monitor mode, for adult and pediatric patients. The NanoPod capnography module is indicated to provide professionally trained healthcare providers with continuous, noninvasive measurement and monitoring of carbon dioxide concentration in expired and inspired breath and respiration rate. It is indicated for neonatal, pediatric, and adult patients in hospitals, hospital-type facilities, and intra-hospital transport. The NanoPod capnography module provides the clinician with an Integrated Pulmonary Index (IPI). IPI is based on end-tidal carbon dioxide, respiration rate, oxygen saturation, and heart rate. It is a single index of an adult or pediatric patient's ventilatory status displayed on a scale of 1–10, where 10 indicates optimal pulmonary status. IPI monitoring displays a single value representing the patient's pulmonary parameters and alerts clinicians to changes in pulmonary status. IPI is indicated for adult and pediatric patients 1 to 12 years of age only. Warning: IPI is an adjunct and is not intended to replace vital-sign monitoring.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 22, 2026